Hangzhou Alltest Biotech Co. Ltd. A (688606) — Capital Reinvestment Ratio
Hangzhou Alltest Biotech Co. Ltd. A (688606) has a Capital Reinvestment Ratio of 0.69x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥55.21 Million) in capital expenditures (CN¥38.02 Million). See Hangzhou Alltest Biotech Co. Ltd. A balance sheet quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Hangzhou Alltest Biotech Co. Ltd. A Capital Reinvestment Ratio (2016–2025)
This chart tracks Hangzhou Alltest Biotech Co. Ltd. A's Capital Reinvestment Ratio across 10 annual periods. Check Hangzhou Alltest Biotech Co. Ltd. A (688606) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Hangzhou Alltest Biotech Co. Ltd. A (2016–2025)
Year-by-year Capital Reinvestment Ratio for Hangzhou Alltest Biotech Co. Ltd. A from 2016 to 2025. For live market cap and broader valuation context, see Hangzhou Alltest Biotech Co. Ltd. A stock valuation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.06x | CN¥206.59 Million | CN¥219.10 Million | ▲ +58.4% |
| 2024 | 0.67x | CN¥329.52 Million | CN¥220.65 Million | ▼ -96.9% |
| 2023 | 21.54x | CN¥24.76 Million | CN¥533.49 Million | ▲ +10747.3% |
| 2022 | 0.20x | CN¥1.36 Billion | CN¥270.24 Million | ▲ +30.9% |
| 2021 | 0.15x | CN¥923.87 Million | CN¥140.12 Million | ▲ +154.5% |
| 2020 | 0.06x | CN¥622.72 Million | CN¥37.11 Million | ▼ -63.8% |
| 2019 | 0.16x | CN¥91.53 Million | CN¥15.09 Million | ▼ -91.2% |
| 2018 | 1.86x | CN¥18.60 Million | CN¥34.66 Million | ▼ -28.5% |
| 2017 | 2.61x | CN¥19.99 Million | CN¥52.12 Million | ▲ +740.1% |
| 2016 | 0.31x | CN¥6.72 Million | CN¥2.08 Million | — |